Familial intrahepatic cholestasis associated with progressive neuromuscular disease and vitamin E deficiency. 1984

M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada

Three Japanese patients with familial progressive intrahepatic cholestasis developed complications involving neurologic abnormalities characterized by ataxia and pigmentary retinopathy. Serum vitamin E concentrations were extremely low in all patients, suggesting a long-term vitamin E deficiency. High dose oral supplementation of alpha-tocopherol produced normal serum vitamin E levels in two patients. Parenteral administration of vitamin E resulted in no clinical improvement in one patient who first received the treatment at 14 years of age. In the other two patients, the progression of neurological abnormalities was slowed by vitamin E supplementation. Cholestyramine treatment resulted in an apparent decrease in serum vitamin E levels despite oral alpha-tocopherol supplementation.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009468 Neuromuscular Diseases A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA. Amyotonia Congenita,Oppenheim Disease,Cramp-Fasciculation Syndrome,Fasciculation-Cramp Syndrome, Benign,Foley-Denny-Brown Syndrome,Oppenheim's Disease,Benign Fasciculation-Cramp Syndrome,Benign Fasciculation-Cramp Syndromes,Cramp Fasciculation Syndrome,Cramp-Fasciculation Syndromes,Fasciculation Cramp Syndrome, Benign,Fasciculation-Cramp Syndromes, Benign,Foley Denny Brown Syndrome,Neuromuscular Disease,Oppenheims Disease,Syndrome, Cramp-Fasciculation,Syndrome, Foley-Denny-Brown,Syndromes, Cramp-Fasciculation
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002780 Cholestasis, Intrahepatic Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC). Bile Duct Obstruction, Intrahepatic,Biliary Stasis, Intrahepatic,Intrahepatic Cholestasis,Biliary Stases, Intrahepatic,Cholestases, Intrahepatic,Intrahepatic Biliary Stases,Intrahepatic Biliary Stasis,Intrahepatic Cholestases
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile

Related Publications

M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
August 1982, Virchows Archiv. A, Pathological anatomy and histology,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
December 1979, Minerva medica,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
October 2010, Best practice & research. Clinical gastroenterology,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
January 2009, Metabolism: clinical and experimental,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
October 2006, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
September 2012, Clinics and research in hepatology and gastroenterology,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
November 2018, Clinics in liver disease,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
June 1973, Pediatrics,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
January 2009, Orphanet journal of rare diseases,
M Nakagawa, and Y Tazawa, and Y Kobayashi, and M Yamada, and H Suzuki, and T Konno, and K Tada
March 2014, Journal of clinical and experimental hepatology,
Copied contents to your clipboard!